Ozempic (semaglutide) Approval Letter

FDA approved Ozempic (semaglutide) injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Not legal or medical advice.

This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.

U.S. Food and Drug AdministrationApproval letterApproved
Docket / Citation
NDA 209637
Published
2017-12-05
Effective
2017-12-05